ID: ALA46084

Max Phase: Preclinical

Molecular Formula: C8H12O6

Molecular Weight: 204.18

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC1=C(OC)C(C(O)CO)OC1=O

Standard InChI:  InChI=1S/C8H12O6/c1-12-6-5(4(10)3-9)14-8(11)7(6)13-2/h4-5,9-10H,3H2,1-2H3

Standard InChI Key:  PLFZSHMRIUGRDH-UHFFFAOYSA-N

Associated Targets(non-human)

Alpha-amylase 16 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 204.18Molecular Weight (Monoisotopic): 204.0634AlogP: -1.23#Rotatable Bonds: 4
Polar Surface Area: 85.22Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.53CX Basic pKa: CX LogP: -1.69CX LogD: -1.69
Aromatic Rings: 0Heavy Atoms: 14QED Weighted: 0.56Np Likeness Score: 2.18

References

1. Abell AD, Ratcliffe MJ, Gerrard J..  (1998)  Ascorbic acid-based inhibitors of alpha-amylases.,  (13): [PMID:9873419] [10.1016/s0960-894x(98)00298-4]

Source